Key safety concerns include pancreatitis, bullous pemphigoid, joint pain, and an increased risk of heart failure hospitalisation with saxagliptin and alogliptin, as highlighted by the MHRA
It supports improved performance and recovery, making it great for athletes and active individuals
References Marianne C Walsh, Lorraine Brennan, Estelle Pujos-Guillot, Jean-Louis Sbdio, Augustin Scalbert, Ails Fagan, Desmond G Higgins, Michael J Gibney, Influence of acute phytochemical intake on human urinary metabolomic profiles, The American Journal of Clinical Nutrition, Volume 86, Issue 6, December 2007, Pages 16871693, Cassidy A, Dalais FS
Jardiance (empagliflozin) is an SGLT2 inhibitor that works in the kidneys to remove excess glucose through urine, whilst Rybelsus (semaglutide) is a GLP-1 receptor agonist that enhances insulin secretion and reduces appetite